These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19655377)

  • 1. Crystal structure determination of mebendazole form A using high-resolution synchrotron x-ray powder diffraction data.
    Ferreira FF; Antonio SG; Rosa PC; Paiva-Santos Cde O
    J Pharm Sci; 2010 Apr; 99(4):1734-44. PubMed ID: 19655377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
    de Villiers MM; Terblanche RJ; Liebenberg W; Swanepoel E; Dekker TG; Song M
    J Pharm Biomed Anal; 2005 Jul; 38(3):435-41. PubMed ID: 15925244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C.
    Martins FT; Neves PP; Ellena J; Camí GE; Brusau EV; Narda GE
    J Pharm Sci; 2009 Jul; 98(7):2336-44. PubMed ID: 18855910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray powder diffraction structure determination of gamma-butyrolactone at 180 K: phase-problem solution from the lattice energy minimization with two independent molecules.
    Papoular RJ; Allouchi H; Chagnes A; Dzyabchenko A; Carré B; Lemordant D; Agafonov V
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):312-20. PubMed ID: 15914896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and crystal structure of D-mannitol hemihydrate.
    Nunes C; Suryanarayanan R; Botez CE; Stephens PW
    J Pharm Sci; 2004 Nov; 93(11):2800-9. PubMed ID: 15368529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe anhydrate, determined from laboratory powder diffraction data.
    Brüning J; Alig E; Schmidt MU
    Acta Crystallogr C; 2010 Jul; 66(Pt 7):o341-4. PubMed ID: 20603561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
    Brüning J; Schmidt MU
    J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structural characterization, and biological studies of new antimony(III) complexes with thiones. The influence of the solvent on the geometry of the complexes.
    Ozturk II; Hadjikakou SK; Hadjiliadis N; Kourkoumelis N; Kubicki M; Baril M; Butler IS; Balzarini J
    Inorg Chem; 2007 Oct; 46(21):8652-61. PubMed ID: 17850141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powder diffraction study of a coordination polymer comprised of rigid building blocks: [Rh2(O2CCH3)4.mu2-Se2C5H8-Se,Se']infinity.
    Dikarev EV; Shpanchenko RV; Andreini KW; Block E; Jin J; Petrukhina MA
    Inorg Chem; 2004 Sep; 43(18):5558-63. PubMed ID: 15332807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the crystal structure of nifedipine form C by synchrotron powder diffraction.
    Bortolotti M; Lonardelli I; Pepponi G
    Acta Crystallogr B; 2011 Aug; 67(Pt 4):357-64. PubMed ID: 21775814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The series of molecular conductors and superconductors ET4[AFe(C2O4)3]·PhX (ET = bis(ethylenedithio)tetrathiafulvalene; (C2O4)2- = oxalate; A+ = H3O+, K+; X = F, Cl, Br, and I): influence of the halobenzene guest molecules on the crystal structure and superconducting properties.
    Coronado E; Curreli S; Giménez-Saiz C; Gómez-García CJ
    Inorg Chem; 2012 Jan; 51(2):1111-26. PubMed ID: 22220827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure determination of thymoquinone by high-resolution X-ray powder diffraction.
    Pagola S; Benavente A; Raschi A; Romano E; Molina MA; Stephens PW
    AAPS PharmSciTech; 2004 Feb; 5(2):e28. PubMed ID: 15760086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences.
    Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM
    Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa.
    Liebenberg W; Dekker TG; Lötter AP; de Villiers MM
    Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin.
    Malpezzi L; Magnone GA; Masciocchi N; Sironi A
    J Pharm Sci; 2005 May; 94(5):1067-78. PubMed ID: 15799018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
    Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
    Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure determination of the β-cyclodextrin-p-aminobenzoic acid inclusion complex from powder X-ray diffraction data.
    Guo P; Su Y; Cheng Q; Pan Q; Li H
    Carbohydr Res; 2011 May; 346(7):986-90. PubMed ID: 21440247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexes of β-cyclodextrin and polymorphs of mebendazole: Physicochemical characterization.
    Saidman E; Chattah AK; Aragón L; Sancho M; Camí G; Garnero C; Longhi M
    Eur J Pharm Sci; 2019 Jan; 127():330-338. PubMed ID: 30445224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Para-derivatized pybox ligands as sensitizers in highly luminescent Ln(III) complexes.
    de Bettencourt-Dias A; Barber PS; Viswanathan S; de Lill DT; Rollett A; Ling G; Altun S
    Inorg Chem; 2010 Oct; 49(19):8848-61. PubMed ID: 20809608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramol--a program for structure analysis of intercalates using molecular simulations: the structure of VOPO4*C6H4O2.
    Koudelka B; Capkova P
    J Mol Model; 2002 May; 8(5):184-90. PubMed ID: 12111386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.